Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Oct 5, 2016

New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring

Xpert Bladder Cancer Monitor Now Commercially Available
Sep 15, 2016

Cepheid Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market

Binary Toxin Gene Reporting has Been Added to the Market Leading Xpert C. difficile Product
Sep 8, 2016

Cepheid Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood

Enabling Accurate and Fast Molecular HIV Viral Load Test from Finger Stick Whole Blood
Sep 6, 2016

Cepheid's Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men

First and Only Trichomonas NAAT Test with Male Urine Claims Cleared for Use in United States
Sep 6, 2016

Cepheid Agrees To Be Acquired By Danaher Corporation For $53 Per Share In Cash

Show per page

Back to Top